Truveta Genome Project exome sequencing for AI-enabled research

Truveta says its member health systems will partner with the Regeneron Genetics Center to sequence up to ten million exomes, and that the de-identified sequencing data added to Truveta Data will let research develop AI that accelerates drug discovery. Truveta reports a $119.5 million Regeneron investment.